FI762698A - - Google Patents
Info
- Publication number
- FI762698A FI762698A FI762698A FI762698A FI762698A FI 762698 A FI762698 A FI 762698A FI 762698 A FI762698 A FI 762698A FI 762698 A FI762698 A FI 762698A FI 762698 A FI762698 A FI 762698A
- Authority
- FI
- Finland
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
- C07D211/66—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61513175A | 1975-09-23 | 1975-09-23 | |
| US61513175 | 1975-09-23 | ||
| US71375676A | 1976-08-12 | 1976-08-12 | |
| US71375676 | 1976-08-12 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI762698A true FI762698A (en) | 1977-03-24 |
| FI61482B FI61482B (en) | 1982-04-30 |
| FI61482C FI61482C (en) | 1982-08-10 |
Family
ID=27087421
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI762698A FI61482C (en) | 1975-09-23 | 1976-09-22 | PROCEDURE FOR THE FRAMEWORK OF THERAPEUTIC NUTRITION N-ARYL-N- (1-L-4-PIPERIDINYL) -ARYLACETAMIDER |
Country Status (29)
| Country | Link |
|---|---|
| JP (1) | JPS6016417B2 (en) |
| AT (1) | AT363935B (en) |
| AU (1) | AU510029B2 (en) |
| BG (1) | BG27543A3 (en) |
| CA (1) | CA1068271A (en) |
| CH (1) | CH628623A5 (en) |
| CS (1) | CS222663B2 (en) |
| DE (1) | DE2642856A1 (en) |
| DK (1) | DK150478C (en) |
| ES (1) | ES451768A1 (en) |
| FI (1) | FI61482C (en) |
| FR (1) | FR2325377A1 (en) |
| GB (1) | GB1539473A (en) |
| GR (1) | GR58469B (en) |
| HU (1) | HU172964B (en) |
| IE (1) | IE43802B1 (en) |
| IL (1) | IL50522A (en) |
| IT (1) | IT1073893B (en) |
| LU (1) | LU75837A1 (en) |
| NL (1) | NL187267C (en) |
| NO (1) | NO147672C (en) |
| NZ (1) | NZ181972A (en) |
| PH (1) | PH12497A (en) |
| PL (2) | PL117323B1 (en) |
| PT (1) | PT65631B (en) |
| RO (1) | RO70079A (en) |
| SE (1) | SE427839B (en) |
| SU (1) | SU747424A3 (en) |
| YU (1) | YU39973B (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA765684B (en) * | 1975-09-23 | 1978-04-26 | Janssen Pharmaceutica Nv | Novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides |
| JPS62260786A (en) * | 1986-05-08 | 1987-11-13 | 株式会社ヘキトク | Line system for manufacturing smoked roof tile |
| JO2769B1 (en) | 2005-10-26 | 2014-03-15 | جانسين فارماسوتيكا ان. في | Fast Dissociting Dopamine 2 Receptor Antagonists |
| JO2642B1 (en) | 2006-12-08 | 2012-06-17 | جانسين فارماسوتيكا ان. في | Fast Dissociating Dopamine 2 Receptor Antagonists |
| JO2849B1 (en) | 2007-02-13 | 2015-03-15 | جانسين فارماسوتيكا ان. في | Fast -Dissociating Dopamine 2 Receptor Antagonists |
| ES2400710T3 (en) | 2007-04-23 | 2013-04-11 | Janssen Pharmaceutica, N.V. | Tia (dia) zoles as fast dissociation dopamine 2 receptor antagonists |
| JP2010525013A (en) * | 2007-04-23 | 2010-07-22 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists |
| US8906921B2 (en) | 2007-04-23 | 2014-12-09 | Janssen Pharmaceutica Nv | 4-alkoxypyridazine derivatives as fast dissociating dopamine 2 receptor antagonists |
| WO2010000456A1 (en) | 2008-07-03 | 2010-01-07 | Janssen Pharmaceutica Nv | Substituted 6- (1-piperazinyl) -pyridazines as 5-ht6 receptor antagonists |
| EA019048B1 (en) | 2008-07-31 | 2013-12-30 | Янссен Фармацевтика Нв | Piperazin-1-yl-trifluoromethyl-substituted pyridines as fast dissociating dopamine 2 receptor antagonists |
-
1976
- 1976-09-06 NO NO763054A patent/NO147672C/en unknown
- 1976-09-08 NZ NZ181972A patent/NZ181972A/en unknown
- 1976-09-16 FR FR7627870A patent/FR2325377A1/en active Granted
- 1976-09-17 AU AU17878/76A patent/AU510029B2/en not_active Expired
- 1976-09-20 LU LU75837A patent/LU75837A1/xx unknown
- 1976-09-20 RO RO7687590A patent/RO70079A/en unknown
- 1976-09-20 CA CA261,551A patent/CA1068271A/en not_active Expired
- 1976-09-21 CH CH1194876A patent/CH628623A5/en not_active IP Right Cessation
- 1976-09-21 JP JP51112527A patent/JPS6016417B2/en not_active Expired
- 1976-09-21 IT IT51370/76A patent/IT1073893B/en active
- 1976-09-21 IL IL50522A patent/IL50522A/en unknown
- 1976-09-21 GR GR51742A patent/GR58469B/en unknown
- 1976-09-21 GB GB39099/76A patent/GB1539473A/en not_active Expired
- 1976-09-22 PL PL1976216213A patent/PL117323B1/en unknown
- 1976-09-22 ES ES451768A patent/ES451768A1/en not_active Expired
- 1976-09-22 IE IE2095/76A patent/IE43802B1/en unknown
- 1976-09-22 PL PL19257876A patent/PL192578A1/en not_active IP Right Cessation
- 1976-09-22 FI FI762698A patent/FI61482C/en not_active IP Right Cessation
- 1976-09-22 YU YU2336/76A patent/YU39973B/en unknown
- 1976-09-22 SE SE7610501A patent/SE427839B/en not_active IP Right Cessation
- 1976-09-22 NL NLAANVRAGE7610513,A patent/NL187267C/en not_active IP Right Cessation
- 1976-09-22 CS CS766139A patent/CS222663B2/en unknown
- 1976-09-22 PH PH18928A patent/PH12497A/en unknown
- 1976-09-22 DK DK427876A patent/DK150478C/en active
- 1976-09-22 HU HU76JA00000767A patent/HU172964B/en not_active IP Right Cessation
- 1976-09-22 PT PT65631A patent/PT65631B/en unknown
- 1976-09-22 AT AT0702976A patent/AT363935B/en not_active IP Right Cessation
- 1976-09-23 BG BG7634265A patent/BG27543A3/en unknown
- 1976-09-23 SU SU762405548A patent/SU747424A3/en active
- 1976-09-23 DE DE19762642856 patent/DE2642856A1/en active Granted
Also Published As
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |
Owner name: JANSSEN PHARMACEUTICA N.V. |